Article
Production of a high level of specific IgG4 antibody associated with resistance to albendazole treatment in HLA-DRB1*0901-positive patients with strongyloidiasis.
The American journal of tropical medicine and hygiene - 1 Oct 1999
Satoh M, Toma H, Sato Y, Kikuchi M, Takara M, Shiroma Y, Kiyuna S, Hirayama K
Abstract excerpt
Strongyloidiasis, a human intestinal infection with Strongyloides stercoralis, is difficult to treat with drugs. The factors influencing this phenomenon remain unclear. To determine the host factors involved in response to treatment, 46 patients with strongyloidiasis were treated with albendazole, followed-up for 1 year, and separated into two groups: cured and non-cured. Serum levels of specific IgA, IgE, IgG,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
